| 000 | 01197 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250512061118.0 | ||
| 264 | 0 | _c19870521 | |
| 008 | 198705s 0 0 eng d | ||
| 022 | _a0004-4172 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aThale, J | |
| 245 | 0 | 0 |
_aElectrophysiologic effects of asocainol, a new antiarrhythmic agent with predominant class I action. _h[electronic resource] |
| 260 |
_bArzneimittel-Forschung _cJan 1987 |
||
| 300 |
_a14-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Arrhythmia Agents _xpharmacology |
| 650 | 0 | 4 |
_aAzocines _xpharmacology |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 | _aElectric Stimulation |
| 650 | 0 | 4 | _aElectrophysiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Conduction System _xdrug effects |
| 650 | 0 | 4 |
_aHemodynamics _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aRefractory Period, Electrophysiological _xdrug effects |
| 650 | 0 | 4 |
_aVentricular Fibrillation _xphysiopathology |
| 700 | 1 | _aGülker, H | |
| 700 | 1 | _aHagemense, B | |
| 700 | 1 | _aRose, D | |
| 700 | 1 | _aHaverkamp, W | |
| 700 | 1 | _aFrenking, B | |
| 773 | 0 |
_tArzneimittel-Forschung _gvol. 37 _gno. 1 _gp. 14-6 |
|
| 999 |
_c3572567 _d3572567 |
||